http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007138081-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cce1434984c9fd49fad2ac397138231e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b82b9765a312ff51ceaa4b201b7bff70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1d8d9b0cd027dd115d74d28c099ee0ad |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
| filingDate | 2007-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbe9d75d687f5758fb72b505915b0de6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b76cf796f2e8d8eef60f61d857d5dc78 |
| publicationDate | 2007-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2007138081-A1 |
| titleOfInvention | PYRIMIDINO[1',6'-1,2]PYRIDO[3,4-b]INDOLE DERIVATIVES AND THEIR THERAPEUTIC USAGE |
| abstract | This invention concerns the following general formula (I) pyrimidino[1',6'-1,2]pyrido[3,4-b]indole in which R1 represents a hydrogen atom or an alkoxy group on C1-C6; R2 represents a hydrogen atom or an alkyl group on C1-C6; R3 represents a hydrogen atom, an alkyl group on C1-C6 or an aryl group, the aryl group being possibly substituted by an alkyl group on C1-C6 or an alkoxy group on C1-C6; the dotted line between the 2 and 3 positions of the ring is absent, the dotted line between the 3 and 4 positions of the ring represent a bond, formula (II) represents formula (III) and formula (IV) represents formula (V) in which R5 represents a hydrogen atom or an alkyl group on C1-C6b or the dotted line between the 3 and 4 position of the ring is absent, the dotted line between the 2 and 3 positions of the ring represent a bond, formula (IV) represents formula (III) and formula (II) represents formula (VI) in which R4 represents a hydrogen atom or halogen, an alkoxy group on Ci-C6 or an alkyl group on C1-C6; or their mixture, or corresponding pharmaceutically acceptable addition salt, or their isomers, enantiomers, diastereoisomers or their mixtures. It also concerns a preparation method for this compound, a pharmaceutical or cosmetic composition comprising it, and its usage in therapy, especially as a hypnotic agent. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11629149-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10858366-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11453677-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11098051-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019092780-A1 |
| priorityDate | 2006-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 158.